Bacille Calmette–Guerin Vaccine May Be an Effective Tool for COVID-19 Prevention

Bacille Calmette–Guerin Vaccine May Be an Effective Tool for COVID-19 Prevention

Saved in:

Bibliographic Details
Main Authors:	Vinod P. Jerath, Shriram V. Kulkarni, Suranjana Basak
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-01-01
Series:	Indian Journal of Medical Specialities
Online Access:	https://journals.lww.com/10.4103/injms.injms_172_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
by: Paola Villanueva, et al.
Published: (2022-01-01)

Utility of Fine Needle Aspiration Cytology in Bacille Calmette–Guerin Lymphadenitis: An Institutional Experience
by: Saba Naaz, et al.
Published: (2024-11-01)

Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda
by: Diana Sitenda, et al.
Published: (2025-03-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
by: B N Shiva Prasad
Published: (2022-01-01)

Interferon (IFN)-gamma (γ) inducible protein 10 (IP-10) in the diagnosis of latent and active tuberculosis in Bacille Calmette Guerin (BCG)-vaccinated pediatric population.
by: Magdalena Druszczynska, et al.
Published: (2025-01-01)

Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19.
by: Lucy Chimoyi, et al.
Published: (2020-01-01)

Disseminated Granulomatous Disease from Intravesical Instillation of Bacillus Calmette-Guerin
by: Sayed Ab. Reshad Ghafouri, et al.
Published: (2018-01-01)

Reaction at the Bacillus Calmette–Guérin Inoculation Site in Patients with Kawasaki Disease
by: Chi-Chieh Lai, et al.
Published: (2013-02-01)

<i>Bacillus Calmette–Guérin</i> Vaccination Promotes Efficient and Comprehensive Immune Modulation in Guinea Pig Models
by: In-Ohk Ouh, et al.
Published: (2025-03-01)

Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis
by: Shunli Cai, et al.
Published: (2025-07-01)

Scar among Bacillus Calmette-Guérin Vaccinated Children Presenting to an Immunisation Clinic at a Tertiary Hospital in Nepal: An Observational Study
by: Ajaya Kumar Dhakal, et al.
Published: (2025-04-01)

Patient-Reported Urinary Symptom Progression After Bacillus Calmette–Guerin Therapy for Bladder Cancer
by: Zorawar Singh, et al.
Published: (2025-02-01)

Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cells.
by: Manjunatha M Venkataswamy, et al.
Published: (2014-01-01)

Central Nervous System Infections Caused by Bacillus Calmette–Guerin: Case Report and Narrative Literature Review
by: Davide Chemello, et al.
Published: (2025-05-01)

Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guérin
by: Seong Jong Eun, et al.
Published: (2020-08-01)

FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer
by: Yang Zhang, et al.
Published: (2022-03-01)

Successful Treatment of Disseminated Bacillus Calmette-Guérin Disease in an HIV-Infected Child with a Linezolid-Containing Regimen
by: Srđan Roglić, et al.
Published: (2016-01-01)

Long-term outcome of Bacillus Calmette-Gue’rin instillation therapy for the upper urinary tract carcinoma in situ
by: Kota Iida, et al.
Published: (2025-06-01)

Unmasking Bacillus Calmette–Guérin Immune Reconstitution Inflammatory Syndrome in a Perinatal HIV Transmission—A Case Report
by: Daniel Ivanov, et al.
Published: (2025-05-01)

The effect of intravesical Bacillus Calmette-Guerin (BCG) treatment on sperm parameters in non-muscle-invasive bladder cancer patients
by: Sergen Sahin, et al.
Published: (2025-05-01)

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin
by: Milošević Radovan, et al.
Published: (2015-01-01)

The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review
by: Chong Ma, et al.
Published: (2023-07-01)

P54 Immunotherapy with Bacillus Calmette-Guérin (BCG) for intermediate- and high-risk patients: A retrospective study in a Latvian population
by: M. Rate, et al.
Published: (2025-07-01)

Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients
by: Alice Turdo, et al.
Published: (2025-04-01)

Performance of the Sysmex UF-1000i System in Screening for Significant Bacteriuria in Patients with Bladder Cancer Who Received Bacillus Calmette-Guérin Treatment
by: Tae Hee Kim, et al.
Published: (2020-08-01)

The role of Uro-Vaxom in reducing infectious adverse effects and improving outcomes in bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer
by: Sookyung Cho, et al.
Published: (2025-07-01)

Predictive value of tumor invasion patterns on intravesical bacillus Calmette–Guérin response for stage T1 high-grade non-muscle-invasive bladder cancer
by: Ismail Ulus, et al.
Published: (2025-07-01)

NOD2 (Nucleotide-Binding Oligomerization Domain-Containing Protein 2)-Mediated Modulation of the Immune Response Induced by BCG (Bacillus Calmette-Guérin) Bacilli
by: Magdalena Jurczak, et al.
Published: (2025-07-01)

Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer
by: Franklin D. Gaylis, et al.
Published: (2024-10-01)

REFLEXÕES SOBRE A RESPONSABILIDADE DO PROFISSIONAL DE ENFERMAGEM NO PROCESSO DE APLICAÇÃO DO BACILO DE CALMETTE E GUÉRIN: REVISÃO DE LITERATURA
by: Vanessa Rodrigues de Oliveira, et al.
Published: (2009-09-01)

Combination of Neoadjuvant Gemcitabine‐Cisplatin and Anti‐Tuberculosis Therapy for a Patient With Muscle‐Invasive Bladder Cancer and Renal Granulomatosis That Progressed After Intravesical Bacillus Calmette‐Guérin Therapy
by: Takahiro Tsumori, et al.
Published: (2025-07-01)

The Braconid Genus Trachypetus Guérin
by: Charles T. Brues
Published: (1920-01-01)

Mesenchymal Stem Cells and COVID-19: Cure, Prevention, and Vaccination
by: Mehrdad Afarid, et al.
Published: (2021-01-01)

Trends in the administration of COVID-19 vaccines with other vaccines in the United States reported to V-safe during December 14, 2020—May 19, 2023
by: Casey E. Parker, et al.
Published: (2024-12-01)

Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison tool.
by: Imelda Trejo, et al.
Published: (2024-01-01)

Conference of experts on vaccine prevention «Regional calendars of immunization of the population – a tool for managing infectious diseases in the territory» (Kirov, May 22, 2019)
by: article Editorial
Published: (2019-11-01)

Notes on the Life History of Pelecium Sulca Tum Guérin
by: George Salt
Published: (1928-01-01)

Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization.
by: Raghu Arghal, et al.
Published: (2025-01-01)